Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10175)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
VCP
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Unspecific Target [Unspecific Target]
In total 1 item(s) under this target | ||||
Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
Responsed Disease | Prostate cancer | ICD-11: 2C82 | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 |
Response regulation | VCP functions as a molecular switch for mitochondrial activity, and this switch is turned off by its relocalization and aggregation when PC3 prostate cancer cells are faced with starvation, consequently lowering mitochondrial activity, ROS production, and the risk of ferroptosis. | |||
Prostate cancer [ICD-11: 2C82]
In total 1 item(s) under this disease | ||||
Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
Target Regulator | Transitional endoplasmic reticulum ATPase (VCP) | Protein coding | ||
Pathway Response | Fatty acid metabolism | hsa01212 | ||
Ferroptosis | hsa04216 | |||
Cell Process | Cell ferroptosis | |||
In Vitro Model |
PC-3 cells | Prostate carcinoma | Homo sapiens | CVCL_0035 |
Response regulation | VCP functions as a molecular switch for mitochondrial activity, and this switch is turned off by its relocalization and aggregation when PC3 prostate cancer cells are faced with starvation, consequently lowering mitochondrial activity, ROS production, and the risk of ferroptosis. | |||